The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
T Cell Proliferation in Response to Interleukins 2 and 7 Requires p38MAP Kinase Activation
Open accessAbstract
Interleukin-2 (IL-2) is a potent T cell mitogen. However, the signaling pathways by which IL-2 mediates its mitogenic effect are not fully understood. One of the members of the mitogen-activated protein kinase (MAPK) family, p42/44MAPK (ERK2/1), is known to be activated by IL-2. We have now investigated the response to IL-2 of two other members of the MAP kinase family, p54MAP kinase (stress-activated protein kinase (SAPK)/Jun-N-terminal kinase (JNK)) and p38MAP kinase (p38/Mpk2/CSBP/RK), which respond primarily to stressful and inflammatory stimuli (e.g. tumor necrosis factor-alpha, IL-1, and lipopolysaccharide). Here we show that IL-2, and another T cell growth factor, IL-7, activate both SAPK/JNK and p38MAP kinase. Furthermore, inhibition of p38MAP kinase activity with a specific pyrinidyl imidazole inhibitor SB203580 that prevents activation of its downstream effector, MAPK-activating protein kinase-2, correlated with suppression of IL-2- and IL-7-driven T cell proliferation. These data indicate that in T cells p38MAP kinase has a role in transducing the mitogenic signal.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hibi, M., Lin, A., Smeal, T., Minden, A., & Karin, M. (1993) · Genes & Development · doi:10.1101/gad.7.11.2135 · Cited by 1,886
Independent Human MAP-Kinase Signal Transduction Pathways Defined by MEK and MKK Isoforms
Dérijard, B., Raingeaud, J., Barrett, T., Wu, I.-H., Han, J., Ulevitch, R. J., & Davis, R. J. (1995) · Science · doi:10.1126/science.7839144 · Cited by 1,555
Cited by
Mitogen-Activated Protein Kinase: Conservation of a Three-Kinase Module From Yeast to Human
WIDMANN, C., GIBSON, S., JARPE, M. B., & JOHNSON, G. L. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.1.143 · Cited by 2,729
The p38 signal transduction pathway Activation and function
Ono, K., & Han, J. (2000) · Cellular Signalling · doi:10.1016/s0898-6568(99)00071-6 · Cited by 1,571
Ushio-Fukai, M., Alexander, R. W., Akers, M., & Griendling, K. K. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.24.15022 · Cited by 650
The stress-activated protein kinase pathways
Tibbles, L. A., & Woodgett, J. R. (1999) · Cellular and Molecular Life Sciences (CMLS) · doi:10.1007/s000180050369 · Cited by 643
Enslen, H., Raingeaud, J., & Davis, R. J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.3.1741 · Cited by 539
Dean, J. L. E., Brook, M., Clark, A. R., & Saklatvala, J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.1.264 · Cited by 492
Self-citationBiology of the Interleukin-2 Receptor
Nelson, B. H., & Willerford, D. M. (1998) · Advances in Immunology · doi:10.1016/s0065-2776(08)60386-7 · Cited by 475
Ardeshna, K. M., Pizzey, A. R., Devereux, S., & Khwaja, A. (2000) · Blood · doi:10.1182/blood.v96.3.1039 · Cited by 430
Protein Phosphorylation and Signal Transduction
Graves, J. D., & Krebs, E. G. (1999) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(98)00056-4 · Cited by 430
Interferon-gamma expression by Th1 effector T cells mediated by the p38 MAP kinase signaling pathway
Rincon, M. (1998) · The EMBO Journal · doi:10.1093/emboj/17.10.2817 · Cited by 417
Irusen, E., Matthews, J. G., Takahashi, A., Barnes, P. J., Chung, K. F., & Adcock, I. M. (2002) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2002.122465 · Cited by 416
A Role for p38MAPK/HSP27 Pathway in Smooth Muscle Cell Migration
Hedges, J. C., Dechert, M. A., Yamboliev, I. A., Martin, J. L., Hickey, E., Weber, L. A., & Gerthoffer, W. T. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.34.24211 · Cited by 396
Defective IL-12 production in mitogen-activated protein (MAP) kinase kinase 3(Mkk3)-deficient mice
Lu, H.-T. (1999) · The EMBO Journal · doi:10.1093/emboj/18.7.1845 · Cited by 384
Cell biology of IL-7, a key lymphotrophin
Jiang, Q., Li, W. Q., Aiello, F. B., Mazzucchelli, R., Asefa, B., Khaled, A. R., & Durum, S. K. (2005) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2005.05.004 · Cited by 342
Requirement for p38α in Erythropoietin Expression
Tamura, K., Sudo, T., Senftleben, U., Dadak, A. M., Johnson, R., & Karin, M. (2000) · Cell · doi:10.1016/s0092-8674(00)00027-1 · Cited by 340
Alternative p38 activation pathway mediated by T cell receptor-proximal tyrosine kinases
Salvador, J. M., Mittelstadt, P. R., Guszczynski, T., Copeland, T. D., Yamaguchi, H., Appella, E., Fornace, A. J., & Ashwell, J. D. (2005) · Nature Immunology · doi:10.1038/ni1177 · Cited by 306
Lali, F. V., Hunt, A. E., Turner, S. J., & Foxwell, B. M. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.10.7395 · Cited by 303
Self-citationp38 MAP Kinase's Emerging Role as a Tumor Suppressor
(2004) · Advances in Cancer Research · doi:10.1016/s0065-230x(04)92005-2 · Cited by 290
Song, K. S., Lee, W.-J., Chung, K. C., Koo, J. S., Yang, E. J., Choi, J. Y., & Yoon, J.-H. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300096200 · Cited by 281
Wan, Y. Y., Chi, H., Xie, M., Schneider, M. D., & Flavell, R. A. (2006) · Nature Immunology · doi:10.1038/ni1355 · Cited by 262
Chuang, S., Wang, I., & Yang, J. (2000) · Carcinogenesis · doi:10.1093/carcin/21.5.423 · Cited by 252
Nagata, Y., & Todokoro, K. (1999) · Blood · doi:10.1182/blood.v94.3.853.415a12_853_863 · Cited by 218
Wang, X., Wu, H., & Miller, A. H. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001339 · Cited by 128
Metadata
- Authors
- Crawley, J. B., Rawlinson, L., Lali, F. V., Page, T. H., Saklatvala, J., & Foxwell, B. J.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 1997-06
- Volume
- 272
- Issue
- 23
- Pages
- 15023-15027
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1982785554
- Cited by
- 245
- References
- 2
- FWCI
- 10.91
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.